Rifabutin.
Mofenson
L M
LM
National Institute of Child Health & Human Development, Rockville, MD, USA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy* / Q000517:prevention & control; D017828:Rifabutin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D017828:Rifabutin